ArticleCardiovascular drugs and therapy2023

The HF-AF ENERGY Trial: Nicotinamide Riboside for the Treatment of Atrial Fibrillation in Heart Failure Patients.

Lisa Pool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.